2023-09-06 13:16:14 ET
More on Viatris
- Seeking Alpha’s Quant Rating on Viatris
- Historical earnings data for Viatris
- Dividend scorecard for Viatris
- Financial information for Viatris
- Viatris Emerges As Challenger In Lucrative Anti-Obesity Drugs Market
- Viatris: Turning Point For Cheap Pharma Stock
- Viatris Q2 2023 Earnings Review: Buy, Sell, Or Hold After Mixed Results?
- Viatris Inc. ( VTRS ) Q2 2023 Earnings Call Transcript
- Viatris wins tentative FDA approval for HIV therapy in children
- Generic drug prices have dropped significantly since 2006 - report
- Viatris goes ex-dividend today
- S&P changes outlook on Viatris to negative
For further details see:
Viatris in talks to selll European OTC assets to CVC unit - report